Professor, School of Nursing, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Professor Emeritus, School of Nursing, University of California, San Francisco, California, USA.
P R Health Sci J. 2022 Sep;41(3):111-116.
To evaluate at-home opioid and benzodiazepine use, the degrees of pain and anxiety, and the incidence of probable withdrawal in post-discharge Trauma Intensive Care Unit (TICU) survivors.
This was an exploratory study of post-TICU survivors who had participated in a previous study of opioid and benzodiazepine withdrawal. We surveyed survivors by telephone asking for retrospective information (during their first 4-months postdischarge- Time 1) and current information (around 2-years post-discharge- Time 2).
A mostly male (82%), young (median 38 years [IQR, 28-52]) sample of 27 TICU survivors reported using opioids (56%) at Time 1 for a median of 30 (IQR,14-90) days. Twelve percent of 26 survivors were still using opioids at Time 2. Sixty percent of the survivors had pain during Time 1, a median pain score of 6 (IQR, 5-8) on a 0-10 numeric rating scale (NRS).; 57% had pain at Time 2, median NRS score=6 (IQR, 4-7). Sixty-five percent of survivors had anxiety during Time 1, NRS median=7 (IQR, 5-9); 50% had anxiety at Time 2, NRS median= 6 (IQR, 3-7). At Time 1, 26% used prescribed benzodiazepines, and 12% used benzodiazepines at Time 2. Five and one of the 27 patients reported symptoms of opioid or benzodiazepine withdrawal, respectively, upon discontinuation or weaning.
Many TICU survivors had discontinued opioid/benzodiazepine prescriptions by 4-months post discharge while half reporting pain/anxiety for up to 2-years. Investigating the effects of acute-to-chronic pain in ICU survivors and gaining a better understanding of the mechanisms of prolonged opioid use are warranted.
评估创伤加强治疗病房(TICU)出院后患者的阿片类药物和苯二氮䓬类药物的居家使用情况、疼痛和焦虑程度以及可能出现的戒断症状。
这是一项对 TICU 出院后幸存者的探索性研究,这些患者曾参与过一项关于阿片类药物和苯二氮䓬类药物戒断的先前研究。我们通过电话对幸存者进行调查,询问他们出院后 4 个月内(第 1 次随访,时间 1)和当前的信息(约 2 年后,时间 2)。
一个主要由男性(82%)组成的年轻(中位数 38 岁[IQR,28-52])TICU 幸存者样本,在时间 1 时报告使用阿片类药物(56%),中位数使用时长为 30 天(IQR,14-90)。在时间 2 时,仍有 12%的 26 名幸存者在使用阿片类药物。60%的幸存者在时间 1 时存在疼痛,疼痛的中位数为 0-10 数字评分量表(NRS)的 6 分(IQR,5-8);57%的幸存者在时间 2 时存在疼痛,NRS 中位数=6(IQR,4-7)。65%的幸存者在时间 1 时存在焦虑,NRS 中位数=7(IQR,5-9);50%的幸存者在时间 2 时存在焦虑,NRS 中位数=6(IQR,3-7)。在时间 1 时,26%的患者使用了处方苯二氮䓬类药物,而 12%的患者在时间 2 时使用了苯二氮䓬类药物。在 27 名患者中,有 5 名和 1 名患者分别报告在停止或逐渐减少使用阿片类药物或苯二氮䓬类药物时出现了戒断症状。
许多 TICU 幸存者在出院后 4 个月内已停止使用阿片类药物/苯二氮䓬类药物处方,但仍有一半的患者报告在长达 2 年内存在疼痛/焦虑。因此,有必要研究 ICU 幸存者急性到慢性疼痛的影响,并深入了解长期使用阿片类药物的机制。